Literature DB >> 30703543

Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative.

C Zeng1, N E Lane2, D J Hunter3, J Wei4, H K Choi5, T E McAlindon6, H Li7, N Lu8, G Lei9, Y Zhang10.   

Abstract

OBJECTIVE: A recent randomized clinical trial reported that repeated intra-articular corticosteroids (IACs) were associated with a greater cartilage loss. This study aimed to examine the relation of IACs to knee radiographic osteoarthritis (ROA) progression in a real-world setting.
DESIGN: A cohort that initiated IACs and a comparison cohort without IACs from participants with mild to moderate knee ROA in the Osteoarthritis Initiative (OAI) were assembled (from 0-month to 48-month). Two measures of knee ROA progression were assessed during the follow-up period: (1) an increase in Kellgren and Lawrence (KL) grade by ≥1 grade or having a knee replacement (i.e., KL grade worsening); and (2) a decrease in joint space width (JSW) by ≥0.7 mm or having a knee replacement (i.e., JSW worsening). The associations of IACs initiation using a propensity-score matched cohort study and continuous IACs using marginal structural models with the risk of knee ROA progression were examined.
RESULTS: Among 684 propensity-score matched participants at baseline (148 IACs initiators, 536 comparators), 65 knees (21.7/100 person-years) in the IACs initiation cohort and 90 knees (7.1/100 person-years) in the comparison cohort experienced KL worsening. The hazard ratios (HRs) of KL worsening from IACs initiation and continuous IACs were 3.02 (95% confidence interval [CI], 2.19-4.16) and 4.67 (95% CI, 2.92-7.47), respectively. The corresponding HRs of JSW worsening were 2.93 (95% CI, 2.13-4.02) and 3.26 (95% CI, 1.78-5.96), respectively. All HRs for continuous use of IACs were further away from the null.
CONCLUSIONS: IACs, especially continuous IACs, may be associated with an increased risk of knee ROA progression.
Copyright © 2019 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cohort; Corticosteroids; Osteoarthritis; Progression

Mesh:

Substances:

Year:  2019        PMID: 30703543     DOI: 10.1016/j.joca.2019.01.007

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  37 in total

1.  Intra-articular Corticosteroid Injections for the Treatment of Hip and Knee Osteoarthritis-related Pain: Considerations and Controversies with a Focus on Imaging-Radiology Scientific Expert Panel.

Authors:  Ali Guermazi; Tuhina Neogi; Jeffrey N Katz; C Kent Kwoh; Philip G Conaghan; David T Felson; Frank W Roemer
Journal:  Radiology       Date:  2020-10-20       Impact factor: 11.105

2.  Progression of Knee Osteoarthritis With Use of Intraarticular Glucocorticoids Versus Hyaluronic Acid.

Authors:  Justin Bucci; Xiaoyang Chen; Michael LaValley; Michael Nevitt; James Torner; Cora E Lewis; David T Felson
Journal:  Arthritis Rheumatol       Date:  2021-12-30       Impact factor: 10.995

3.  A Comprehensive Update of Prolotherapy in the Management of Osteoarthritis of the Knee.

Authors:  Alex Tang Zhao; Cassidy J Caballero; Linh T Nguyen; Hunter C Vienne; Christopher Lee; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

Review 4.  Joint interventions in osteoarthritis.

Authors:  Michel D Crema; Ali Guermazi; Frank W Roemer
Journal:  Skeletal Radiol       Date:  2022-08-18       Impact factor: 2.128

Review 5.  Consensus Guidelines on Interventional Therapies for Knee Pain (STEP Guidelines) from the American Society of Pain and Neuroscience.

Authors:  Corey W Hunter; Timothy R Deer; Mark R Jones; George C Chang Chien; Ryan S D'Souza; Timothy Davis; Erica R Eldon; Michael F Esposito; Johnathan H Goree; Lissa Hewan-Lowe; Jillian A Maloney; Anthony J Mazzola; John S Michels; Annie Layno-Moses; Shachi Patel; Jeanmarie Tari; Jacqueline S Weisbein; Krista A Goulding; Anikar Chhabra; Jeffrey Hassebrock; Chris Wie; Douglas Beall; Dawood Sayed; Natalie Strand
Journal:  J Pain Res       Date:  2022-09-08       Impact factor: 2.832

6.  Externally validated models for first diagnosis and risk of progression of knee osteoarthritis.

Authors:  Philippa Grace McCabe; Paulo Lisboa; Bill Baltzopoulos; Ivan Olier
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

7.  Cooled radiofrequency ablation of the genicular nerves for chronic pain due to osteoarthritis of the knee: a cost-effectiveness analysis compared with intra-articular hyaluronan injections based on trial data.

Authors:  Mehul J Desai; Anthony Bentley; William A Keck
Journal:  BMC Musculoskelet Disord       Date:  2022-05-24       Impact factor: 2.562

8.  Varus-valgus knee laxity is related to a higher risk of knee osteoarthritis incidence and structural progression: data from the osteoarthritis initiative.

Authors:  Mingyang Li; Yi Zeng; Yong Nie; Yuangang Wu; Yuan Liu; Limin Wu; Bin Shen
Journal:  Clin Rheumatol       Date:  2022-01-22       Impact factor: 2.980

9.  Risk factors associated with the occurrence of total knee arthroplasty in patients with knee osteoarthritis: a nested case-control study.

Authors:  Jean-Pierre Pelletier; Marc Dorais; Patrice Paiement; Jean-Pierre Raynauld; Johanne Martel-Pelletier
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-04-29       Impact factor: 3.625

Review 10.  Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review.

Authors:  Jeffrey N Katz; Kaetlyn R Arant; Richard F Loeser
Journal:  JAMA       Date:  2021-02-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.